Raised where liver disease was prevalent, surgeon commits his career to discovering and delivering novel therapies for liver cancer
Growing up in South Korea where viral hepatitis infections are prevalent, Seung Lee, M.D., Ph.D., observed a high rate of liver cancer, a disease often prompted by the inflammation from chronic infection. Hepatocellular carcinoma is the most common form of liver cancer and the second-leading cause of cancer deaths worldwide, but there isn’t a successful drug to treat the disease in advanced stages. Early on, Lee knew he wanted to commit his career to caring for patients affected by liver disease and to discovering therapies that can effectively treat or cure liver cancer.
Massey researcher awarded $450K to identify effective drug combinations for triple negative breast cancer
VCU Massey Cancer Center researcher Chuck Harrell, Ph.D., was awarded $450,000 from Susan G. Komen to identify new drug combinations that can be used to more effectively treat a key population of advanced breast cancer patients.
National clinical trial led by Massey researcher provides mastectomy alternative for recurrent breast cancer
Mastectomy has historically been the standard treatment for breast cancer patients experiencing recurrence after an initial lumpectomy and whole-breast radiation. Now, a phase 2 clinical trial led by Douglas W. Arthur, M.D., chair and professor in the Department of Radiation Oncology at VCU Massey Cancer Center and VCU School of Medicine, has demonstrated an effective alternative.
Brighten up your holiday meals with these healthy and tasty recipes featuring a loaf of sweet gingerbread and a colorful pomegranate salsa.
VCU Massey Cancer Center physicians have been recognized by Our Health Richmond magazine's annual Best Bedside Manner Awards for the compassionate care, empathy and attentiveness that they provide to their patients. Winners were selected based on more than 30,000 votes from community members and medical professionals.